The first consumer experiences powered by true molecular medicine infrastructure are now live at lite.dendrite.com. Take a quiz built from your own genome. Read the seven-chapter story of your biology ...

Oral argument heard Friday, May 1, 2026 in Smart Approaches to Marijuana v. Kennedy — with Ilya Shapiro arguing for ...

Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per monthBrief Summary:GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per ...

LINCOLN, NE / ACCESS Newswire / May 1, 2026 / Securitas Healthcare, a leading provider of real‑time visibility and protection ...

Also Announces Extension of IR Program VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Onco-Innovations Limited (CBOE CA:ONCO ...

Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced it will present new data related to ...

New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure ...

Acquisition strengthens embedded research ERO model, expands network to 35+ sites across six states  OXNARD, CA / ACCESS ...

TaeWoong Medical USA today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Niti-S SPAXUS™ Stent, further strengthening its portfolio of endoscopic ultrasound ...

Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical TechnologyLOS ANGELES & ATLANTA--(BUSINESS ...

Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have ...

UCB acquires IMIDomics’ Patient Insight Business, gaining access to one of the world’s most comprehensive multi omic datasets for immune mediated inflammatory diseasesPatient Insight Business enhances ...